AmCad Biomed Corporation received the 2019 Taiwan Excellence Award for developing an industry transformative Obstructive Sleep Apnea (OSA) detection system. AmCAD-UO is an innovative solution to assist physicians in evaluating the risk of Obstructive Sleep Apnea (OSA). The evaluation process is performed on awake patients in just 10 minutes using a compact ultrasound device equipped with laser-guided positioning system and computer-assisted detection (CAD) software. The automated scanning procedure not only provides the upper airway assessment but also creates 3D reconstruction images for doctors’ to use as companion diagnostics when recommending treating for OSA.